Cancer Therapy: Low‐Dose Prostate Cancer Brachytherapy with Radioactive Palladium–Gold Nanoparticles (Adv. Healthcare Mater. 4/2017) | Zendy

LaprisePelletier Myriam | Zendy; Lagueux Jean | Zendy; Côté MarieFrance | Zendy; LaGrange Thomas | Zendy; Fortin MarcAndré | Zendy

Premium

Cancer Therapy: Low‐Dose Prostate Cancer Brachytherapy with Radioactive Palladium–Gold Nanoparticles (Adv. Healthcare Mater. 4/2017)

Author(s) -

LaprisePelletier Myriam,

Lagueux Jean,

Côté MarieFrance,

LaGrange Thomas,

Fortin MarcAndré

Publication year - 2017

Publication title -

advanced healthcare materials

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.288

H-Index - 90

eISSN - 2192-2659

pISSN - 2192-2640

DOI - 10.1002/adhm.201770018

Subject(s) - brachytherapy , prostate cancer , cancer , medicine , radiation therapy , colloidal gold , nuclear medicine , materials science , prostate , oncology , biomedical engineering , nanoparticle , radiology , nanotechnology

Prostate cancer is often treated by internal radiotherapy (brachytherapy), by which tens of radioactive implants made of massive metal « seeds » are inserted in the diseased tissue. Article number 1601120 by Marc‐André Fortin and co‐workers, reports on a new technology based on the injection of radioactive gold nanoparticles. The nanoparticles diffuse into the tumour, where they progressively deliver a radiotherapeutic dose more precisely and with fewer potential side‐effects.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research